Find Limaprost Alfadex manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

EU WC

EU WC

0

NDC API

NDC API

0

VMF

NDC API

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 88852-12-4, Op 1306 - alpha-cyclodextrin, 17s,20-dimethyl-trans-delta2-pge1 compd. with alpha-cyclodextrin, 2-heptenoic acd, 7-((1r,2r,3r)-3-hydroxy-2-((1e,3s,5s)-3-hydroxy-5-methyl-1-nonenyl)-5-oxocyclopentyl)-, (2e)-, compd. with alpha-cyclodextrin, Alpha-cyclodextrin, compd. with (2e,11alpha,13e,15s,17s)-11,15-dihydroxy-17,20-dimethyl-9-oxoprosta-2,13-dien-1-oic acid, Schembl3749588
Molecular Formula
C57H94O35
Molecular Weight
1339.3  g/mol
InChI Key
AURWGUVCKQSRJX-UYCJUBBXSA-N

Limaprost Alfadex
1 2D Structure

Limaprost Alfadex

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(1S,3R,5R,6S,8R,10R,11S,13R,15R,16S,18R,20R,21S,23R,25R,26S,28R,30R,31R,32R,33R,34R,35R,36R,37R,38R,39R,40R,41R,42R)-5,10,15,20,25,30-hexakis(hydroxymethyl)-2,4,7,9,12,14,17,19,22,24,27,29-dodecaoxaheptacyclo[26.2.2.23,6.28,11.213,16.218,21.223,26]dotetracontane-31,32,33,34,35,36,37,38,39,40,41,42-dodecol;(Z)-6-[(1R,2R,3R)-3-hydroxy-2-[(E,3S,5S)-3-hydroxy-5-methylnon-1-enyl]-5-oxocyclopentyl]hex-2-enoic acid
2.1.2 InChI
InChI=1S/C36H60O30.C21H34O5/c37-1-7-25-13(43)19(49)31(55-7)62-26-8(2-38)57-33(21(51)15(26)45)64-28-10(4-40)59-35(23(53)17(28)47)66-30-12(6-42)60-36(24(54)18(30)48)65-29-11(5-41)58-34(22(52)16(29)46)63-27-9(3-39)56-32(61-25)20(50)14(27)44;1-3-4-8-15(2)13-16(22)11-12-18-17(19(23)14-20(18)24)9-6-5-7-10-21(25)26/h7-54H,1-6H2;7,10-12,15-18,20,22,24H,3-6,8-9,13-14H2,1-2H3,(H,25,26)/b;10-7-,12-11+/t7-,8-,9-,10-,11-,12-,13-,14-,15-,16-,17-,18-,19-,20-,21-,22-,23-,24-,25-,26-,27-,28-,29-,30-,31-,32-,33-,34-,35-,36-;15-,16+,17+,18+,20+/m10/s1
2.1.3 InChI Key
AURWGUVCKQSRJX-UYCJUBBXSA-N
2.1.4 Canonical SMILES
CCCCC(C)CC(C=CC1C(CC(=O)C1CCCC=CC(=O)O)O)O.C(C1C2C(C(C(O1)OC3C(OC(C(C3O)O)OC4C(OC(C(C4O)O)OC5C(OC(C(C5O)O)OC6C(OC(C(C6O)O)OC7C(OC(O2)C(C7O)O)CO)CO)CO)CO)CO)O)O)O
2.1.5 Isomeric SMILES
CCCC[C@H](C)C[C@@H](/C=C/[C@H]1[C@@H](CC(=O)[C@@H]1CCC/C=C\C(=O)O)O)O.C([C@@H]1[C@@H]2[C@@H]([C@H]([C@H](O1)O[C@@H]3[C@H](O[C@@H]([C@@H]([C@H]3O)O)O[C@@H]4[C@H](O[C@@H]([C@@H]([C@H]4O)O)O[C@@H]5[C@H](O[C@@H]([C@@H]([C@H]5O)O)O[C@@H]6[C@H](O[C@@H]([C@@H]([C@H]6O)O)O[C@@H]7[C@H](O[C@H](O2)[C@@H]([C@H]7O)O)CO)CO)CO)CO)CO)O)O)O
2.2 Synonyms
2.2.1 MeSH Synonyms

1. Limaprost-alfadex

2. Limaprost-alpha-cyclodextrin Complex

2.2.2 Depositor-Supplied Synonyms

1. 88852-12-4

2. Op 1306 - Alpha-cyclodextrin

3. 17s,20-dimethyl-trans-delta2-pge1 Compd. With Alpha-cyclodextrin

4. 2-heptenoic Acd, 7-((1r,2r,3r)-3-hydroxy-2-((1e,3s,5s)-3-hydroxy-5-methyl-1-nonenyl)-5-oxocyclopentyl)-, (2e)-, Compd. With Alpha-cyclodextrin

5. Alpha-cyclodextrin, Compd. With (2e,11alpha,13e,15s,17s)-11,15-dihydroxy-17,20-dimethyl-9-oxoprosta-2,13-dien-1-oic Acid

6. Schembl3749588

7. 2,4,7,9,12,14,17,19,22,24,27,29-dodecaoxaheptacyclo(26.2.2.23,6.28,11.213,16.218,21.223,26)detetracontane, Alpha-cyclodextrin Deriv.

8. Alpha-cyclodextrin, Compd. With (2e)-7-((1r,2r,3r)-3-hydroxy-2-((1e,3s,5s)-3-hydroxy-5-methyl-1-nonenyl)-5-oxocyclopentyl)-2-heptenoic Acid

9. Prosta-2,13-dien-1-oic Acid, 11,15-dihydroxy-17,20-dimethyl-9-oxo-, (2e,11alpha,13e,15s,17s)-, Compd With Alpha-cyclodextrin

2.3 Create Date
2006-04-28
3 Chemical and Physical Properties
Molecular Weight 1339.3 g/mol
Molecular Formula C57H94O35
Hydrogen Bond Donor Count21
Hydrogen Bond Acceptor Count35
Rotatable Bond Count18
Exact Mass1338.5575647 g/mol
Monoisotopic Mass1338.5575647 g/mol
Topological Polar Surface Area570 Ų
Heavy Atom Count92
Formal Charge0
Complexity1740
Isotope Atom Count0
Defined Atom Stereocenter Count35
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count2
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2

API SUPPLIERS

read-more
read-more

01

Chirogate International

Taiwan

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Antibody Engineering
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothChirogate is a professional Prostaglandin manufacturer.

Flag Taiwan
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Chirogate CB

02

EUROAPI

France

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Antibody Engineering
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothEUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Flag France
Digital Content Digital Content
USDMF CEP/COS JDMF arrow-down EU-WC NDC KDMF arrow-down VMF CN, ROW arrow-down AUDIT
EUROAPI Compnay Banner

03

EUROAPI

France

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Antibody Engineering
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothEUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Flag France
Digital Content Digital Content
USDMF CEP/COS JDMF arrow-down EU-WC NDC KDMF arrow-down VMF CN, ROW arrow-down AUDIT
EUROAPI Compnay Banner

04

Kanto Chemical

Japan

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Antibody Engineering
Not Confirmed
arrow

Kanto Chemical

Japan

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Antibody Engineering
Not Confirmed
USDMF CEP/COS JDMF arrow-down EU-WC NDC KDMF VMF Others AUDIT
blank

05

Zhejiang Ausun Pharmaceutical

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Antibody Engineering
Not Confirmed
arrow

06

Yonsung Fine Chemicals

South Korea

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Antibody Engineering
Not Confirmed
arrow

Yonsung Fine Chemicals

South Korea

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Antibody Engineering
Not Confirmed
USDMF CEP/COS JDMF arrow-down EU-WC NDC KDMF arrow-down VMF Others AUDIT
blank

07

Zhejiang Tiantai Pharmaceutical

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Antibody Engineering
Not Confirmed
arrow
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty